Top Suppliers:I want be here


138168-48-6

138168-48-6 structure
138168-48-6 structure
  • Name: Tyroserleutide (YSL)
  • Chemical Name: Tyroserleutide
  • CAS Number: 138168-48-6
  • Molecular Formula: C18H27N3O6
  • Molecular Weight: 381.423
  • Catalog: Research Areas Cancer
  • Create Date: 2019-01-02 09:17:05
  • Modify Date: 2025-08-25 20:11:54
  • Tyroserleutide (YSL), isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2].

Name Tyroserleutide
Synonyms L-Tyrosyl-L-seryl-L-leucine
L-Leucine, L-tyrosyl-L-seryl-
Description Tyroserleutide (YSL), isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2].
Related Catalog
Target

Antitumor tripeptide[1][2]

In Vitro Tyroserleutide (YSL) exhibits immuno-modulating effects, such as enhancing concanavalin (ConA) induced proliferation of mouse spleen lymphocytes, phagocytosis of mouse peritoneal macrophages, and the activity of natural killer (NK) cells[1]. Tyroserleutide (YSL), an immunologically therapeutic tripeptide, can promote hepatocarcinoma cell (H22) apoptosis through downregulating Bcl-2 and cyclin D1 expression[2]. Tyroserleutide is an ideal choice for inducing apoptosis of liver tumor cells[2]. Tyroserleutide inhibits tumor growth and does not cause severe toxicities in the major organs. Tyroserleutide can inhibit tumor cell migration[2].
In Vivo Tyroserleutide (10-80 μg/kg; injection (i.p.) one time every day until mice are dead) displays obvious anti-tumor activity. Tyroserleutide significantly prolongs the survival time of the murine H22 implanted mice[1]. Animal Model: Female Kun-Ming mice (18-22 g, 6 week old) with H22 tumor model[1] Dosage: 10, 20, 40, and 80 μg/kg Administration: Injection (i.p.) one time every day until mice were dead. Result: Survival times are 25.53±14.14, 25.82±14.29, 30.47±17.89, 35.06±20.90 days for 10, 20, 40, and 80 μg/kg, respectively.
References

[1]. Wang C, et al. Studies on the large scale synthesis and anti-tumor activity of YSL. Prep Biochem Biotechnol. 2003 Aug;33(3):189-95.

[2]. Liang P, et al. pH-Triggered Conformational Change of Antp-Based Drug Delivery Platform for Tumor Treatment with Combined Photothermal Therapy and Chemotherapy. Adv Healthc Mater. 2019 Aug;8(15):e1900306.

Density 1.3±0.1 g/cm3
Boiling Point 763.8±60.0 °C at 760 mmHg
Molecular Formula C18H27N3O6
Molecular Weight 381.423
Flash Point 415.7±32.9 °C
Exact Mass 381.189972
LogP 0.89
Vapour Pressure 0.0±2.7 mmHg at 25°C
Index of Refraction 1.577
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.